Literature DB >> 874320

Neutrophil aggregation and swelling induced by chemotactic agents.

J T O'Flaherty, D L Kreutzer, P A Ward.   

Abstract

An assay is described for measuring neutrophil aggregation and cell size with a Coulter Counter equipped with a mean cell volume computer and volume channalyzer. With this assay, it was found that several chemotactically active agents rapidly induce rabbit peritoneal polymorphonuclear neutrophils in suspension to aggregate reversibly. The aggregating activities of these chemotactic agents paralleled their in vitro chemotactic- and in vivo neutropenia-inducing potencies. Neutrophil aggregation may underlie the neutropenia which follows the infusion of these agents into rabbits. Chemotactic agents may also induce polymorphonuclear neutrophils to increase in volume; this effect appears to be independent of aggregation. The volume change develops more slowly and does not appear reversible under the conditions employed. The volume increase may be an expression of pseudopodia formation and membrane ruffling known to develop in neutrophils exposed to chemotactic agents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874320

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils.

Authors:  M Vulcano; M F Alves Rosa; F S Minnucci; A C Cherñavsky; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

2.  Neutrophil aggregation and degranulation. Effect of arachidonic acid.

Authors:  J T O'Flaherty; H J Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

3.  The chemotactic response of tumor cells. A model for cancer metastasis.

Authors:  W C Lam; E J Delikatny; F W Orr; J Wass; J Varani; P A Ward
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

4.  Substances which aggregate neutrophils. Mechanism of action.

Authors:  J T O'Flaherty; H J Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

5.  Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria.

Authors:  P A Henricks; M E van der Tol; J Verhoef
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

6.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.

Authors:  G O Till; K J Johnson; R Kunkel; P A Ward
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

7.  Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.

Authors:  A H Lin; D R Morton; R R Gorman
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

8.  Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes.

Authors:  L A Boxer; R A Haak; H H Yang; J B Wolach; J A Whitcomb; C J Butterick; R L Baehner
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung.

Authors:  J T O'Flaherty; S Cousart; A S Lineberger; E Bond; D A Bass; L R DeChatelet; E S Leake; C E McCall
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

10.  Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist.

Authors:  M Reale; R C Barbacane; S Frydas; G Anogianakis; A Trakatellis; D Dimitriadou; D Vacalis; F C Placido; P De Fazio; E Porreca; C Di Febbo; P Conti
Journal:  Mol Cell Biochem       Date:  1996-06-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.